Tor Biering-Sørensen1,2, Sanjiv J Shah3, Inder Anand4, Nancy Sweitzer5, Brian Claggett1, Li Liu1, Bertram Pitt6, Marc A Pfeffer1, Scott D Solomon1, Amil M Shah1. 1. Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA. 2. Department of Cardiology, Herlev and Gentofte Hospital, University of Copenhagen, Denmark. 3. Cardiology Division, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 4. Cardiovascular Division, VA Medical Center, Minneapolis, MN, USA. 5. Sarver Heart Center, University of Arizona College of Medicine, Tucson, AZ, USA. 6. Cardiology Division, University of Michigan School of Medicine, Ann Arbor, MI, USA.
Abstract
AIMS: Left ventricular mechanical dyssynchrony has been described in heart failure with preserved ejection fraction (HFpEF), but its prognostic significance is not known. METHODS AND RESULTS: Of 3445 patients with HFpEF enrolled in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, dyssynchrony analysis was performed on 424 patients (12%) by multiple speckle tracking echocardiography strain-based criteria. The primary dyssynchrony analysis was the standard deviation of the time to peak longitudinal strain (SD T2P LS). Cox proportional hazards models assessed the association of dyssynchrony with the composite outcome of cardiovascular death or heart failure hospitalization. Mean age was 70 ± 10 years, LVEF was 60 ± 8%, and QRS duration was 101 ± 27 ms. Worse dyssynchrony, reflected in SD T2P LS, was associated with wider QRS, prior myocardial infarction, larger LV volume and mass, and worse systolic (lower LVEF and global longitudinal strain) and diastolic (lower e' and higher E/e') function. During a median follow-up of 2.6 (interquartile range 1.5-3.8) years, 107 patients experienced the composite outcome. Worse dyssynchrony was associated with the composite outcome in unadjusted analysis [hazard ratio (HR) 1.04, 95% confidence interval (CI) 1.01-1.07; P = 0.021, per 10 ms increase], but not after adjusting for clinical characteristics, or after further adjustment for LVEF, AF, NYHA class, stroke, heart rate, creatinine, haematocrit, and QRS duration (HR 1.03, 95% CI 0.99-1.06; P = 0.16, per 10 ms increase). CONCLUSION: Worse LV mechanical dyssynchrony, assessed by speckle tracking echocardiography, is not an independent predictor of adverse outcomes in HFpEF, suggesting that mechanical dyssynchrony is unlikely to be an important mechanism underlying this syndrome. These findings warrant validation in an independent study specifically designed to assess the prognostic utility of mechanical dyssynchrony in HFpEF. TRIAL REGISTRATION: NCT00094302.
RCT Entities:
AIMS: Left ventricular mechanical dyssynchrony has been described in heart failure with preserved ejection fraction (HFpEF), but its prognostic significance is not known. METHODS AND RESULTS: Of 3445 patients with HFpEF enrolled in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, dyssynchrony analysis was performed on 424 patients (12%) by multiple speckle tracking echocardiography strain-based criteria. The primary dyssynchrony analysis was the standard deviation of the time to peak longitudinal strain (SD T2P LS). Cox proportional hazards models assessed the association of dyssynchrony with the composite outcome of cardiovascular death or heart failure hospitalization. Mean age was 70 ± 10 years, LVEF was 60 ± 8%, and QRS duration was 101 ± 27 ms. Worse dyssynchrony, reflected in SD T2P LS, was associated with wider QRS, prior myocardial infarction, larger LV volume and mass, and worse systolic (lower LVEF and global longitudinal strain) and diastolic (lower e' and higher E/e') function. During a median follow-up of 2.6 (interquartile range 1.5-3.8) years, 107 patients experienced the composite outcome. Worse dyssynchrony was associated with the composite outcome in unadjusted analysis [hazard ratio (HR) 1.04, 95% confidence interval (CI) 1.01-1.07; P = 0.021, per 10 ms increase], but not after adjusting for clinical characteristics, or after further adjustment for LVEF, AF, NYHA class, stroke, heart rate, creatinine, haematocrit, and QRS duration (HR 1.03, 95% CI 0.99-1.06; P = 0.16, per 10 ms increase). CONCLUSION: Worse LV mechanical dyssynchrony, assessed by speckle tracking echocardiography, is not an independent predictor of adverse outcomes in HFpEF, suggesting that mechanical dyssynchrony is unlikely to be an important mechanism underlying this syndrome. These findings warrant validation in an independent study specifically designed to assess the prognostic utility of mechanical dyssynchrony in HFpEF. TRIAL REGISTRATION: NCT00094302.
Authors: John Gorcsan; Peter Sogaard; Jeroen J Bax; Jagmeet P Singh; William T Abraham; Jeffrey S Borer; Kenneth Dickstein; Daniel Gras; Henry Krum; Josep Brugada; Michele Robertson; Ian Ford; Johannes Holzmeister; Frank Ruschitzka Journal: Eur Heart J Date: 2015-08-30 Impact factor: 29.983
Authors: Dorit Knappe; Anne-Catherine Pouleur; Amil M Shah; Susan Cheng; Hajime Uno; W Jackson Hall; Mikhail Bourgoun; Elyse Foster; Wojciech Zareba; Ilan Goldenberg; Scott McNitt; Marc A Pfeffer; Arthur J Moss; Scott D Solomon Journal: Circ Heart Fail Date: 2011-05-22 Impact factor: 8.790
Authors: Anne-Catherine Pouleur; Dorit Knappe; Amil M Shah; Hajime Uno; Mikhail Bourgoun; Elyse Foster; Scott McNitt; W Jackson Hall; Wojciech Zareba; Ilan Goldenberg; Arthur J Moss; Marc A Pfeffer; Scott D Solomon Journal: Eur Heart J Date: 2011-05-24 Impact factor: 29.983
Authors: Scott D Solomon; Michael Zile; Burkert Pieske; Adriaan Voors; Amil Shah; Elisabeth Kraigher-Krainer; Victor Shi; Toni Bransford; Madoka Takeuchi; Jianjian Gong; Martin Lefkowitz; Milton Packer; John J V McMurray Journal: Lancet Date: 2012-08-26 Impact factor: 79.321
Authors: Jacob Joseph; Brian C Claggett; Inder S Anand; Jerome L Fleg; Thao Huynh; Akshay S Desai; Scott D Solomon; Eileen O'Meara; Sonja Mckinlay; Bertram Pitt; Marc A Pfeffer; Eldrin F Lewis Journal: JACC Heart Fail Date: 2016-03-30 Impact factor: 12.035
Authors: Angela B S Santos; Elisabeth Kraigher-Krainer; Natalie Bello; Brian Claggett; Michael R Zile; Burkert Pieske; Adriaan A Voors; John J V McMurray; Milton Packer; Toni Bransford; Marty Lefkowitz; Amil M Shah; Scott D Solomon Journal: Eur Heart J Date: 2013-10-27 Impact factor: 29.983
Authors: Valentina Kutyifa; Anne-Catherine Pouleur; Dorit Knappe; Amin Al-Ahmad; Michal Gibinski; Paul J Wang; Scott McNitt; Bela Merkely; Ilan Goldenberg; Scott D Solomon; Arthur J Moss; Wojciech Zareba Journal: JACC Cardiovasc Imaging Date: 2013-04
Authors: Amil M Shah; Sanjiv J Shah; Inder S Anand; Nancy K Sweitzer; Eileen O'Meara; John F Heitner; George Sopko; Guichu Li; Susan F Assmann; Sonja M McKinlay; Bertram Pitt; Marc A Pfeffer; Scott D Solomon Journal: Circ Heart Fail Date: 2013-11-18 Impact factor: 8.790
Authors: Jan Wintrich; Ingrid Kindermann; Christian Ukena; Simina Selejan; Christian Werner; Christoph Maack; Ulrich Laufs; Carsten Tschöpe; Stefan D Anker; Carolyn S P Lam; Adriaan A Voors; Michael Böhm Journal: Clin Res Cardiol Date: 2020-03-31 Impact factor: 5.460